Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers

PHASE4CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

March 31, 2014

Conditions
Diabetic Foot Ulcers
Interventions
OTHER

Tissue

Allograft Tissue Cellular Repair Matrix

OTHER

Control

Non-adherent Dressing

Trial Locations (15)

16602

Blair Orthopedics Associates, Inc, Altoona

27599

UNC at Chapel Hill, Chapel Hill

27710

Duke University Medical Center, Durham

30809

Aiyan Diabetes Center, Evans

32207

River City Clinical Research, Jacksonville

34452

Nature Coast Clinical Research, Inverness

36111

Institute for Advanced Wound Care at Baptist Medical, Montgomery

43214

Ohio Health Research Institute, Columbus

44195

Cleveland Clinic, Cleveland

75235

UT Southwestern Medical Center at Dallas, Dallas

78229

Clincal Trials of Texas, Inc., San Antonio

85306

Clinical Trials of Arizona, Inc., Glendale

92024

ILD Laser and Research Center, Encinitas

08753

Ocean County Foot and Ankle Surgical Associates, Toms River

02886

Omega Medical Research, Warwick

Sponsors
All Listed Sponsors
lead

Osiris Therapeutics

INDUSTRY